GS
VERA icon

GTS Securities’s Vera Therapeutics VERA Stock Holding History

GTS Securities’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,601
Closed -$242K – 4338
2024
Q1 		$242K Buy
+5,601
New +$200K ﹤0.01% 3188

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

GTS Securities's VERA Position: Q2 2024 in Review

GTS Securities sold out of Vera Therapeutics (VERA) in Q2 2024, closing a stake of 5,601 shares — an estimated $242K sold.

GTS Securities first reported a position in VERA in Q1 2024 and held it in 1 quarter. The position peaked at $242K in Q1 2024. 171 funds tracked by Wall St. Rank hold VERA as of Q2 2024.

  • GTS Securities reported no remaining Vera Therapeutics position as of Q2 2024 after selling out during the quarter.
  • GTS Securities sold 5,601 Vera Therapeutics shares in Q2 2024, an estimated $242K.
  • GTS Securities first reported a position in Vera Therapeutics in Q1 2024 and held it in 1 quarter.
  • GTS Securities's Vera Therapeutics position peaked at $242K in Q1 2024.
  • 171 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2024.

Based on GTS Securities's 13F filing for Q2 2024, filed 14 Aug 2024.